MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$6,406K
Net Income
-$95K
Net Profit Margin
-1.48%
EPS
-$0.09
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
6,406
4,600*
4,349
5,604
Cost of revenues
3,829
2,840*
2,699
3,484
Gross profit
2,577
1,760*
1,650
2,120
Research and development
597
573*
557
575
Selling, general and administrative
2,020
2,124*
1,771
1,882
Total operating expenses
2,617
2,697*
2,328
2,457
Loss from operations
-40
-937*
-678
-337
Other expense, net
-290
40*
-271
-394
Loss from operations before income taxes
-330
-898*
-949
-731
Income tax benefit
0
247*
-130
-197
Net loss
-330
-1,145*
-819
-534
Foreign currency translation adjustments
235
565*
174
205
Comprehensive loss
-95
-581
-645
-329
Basic EPS
-0.09
-0.343
-0.48
-0.32
Diluted EPS
-0.09
-0.343
-0.48
-0.32
Basic Average Shares
3,846,000
1,693,000
1,713,000
1,646,000
Diluted Average Shares
3,846,000
1,693,000
1,713,000
1,646,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$95K
Foreign currency
translation adjustments
$235K
Net loss
-$330K
Loss from operations
before income taxes
-$330K
Revenues
$6,406K
Other expense, net
-$290K
Loss from operations
-$40K
Gross profit
$2,577K
Cost of revenues
$3,829K
Total operating
expenses
$2,617K
Selling, general and
administrative
$2,020K
Research and development
$597K
Buy us a coffee
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)